Goldman Sachs had an outstanding 2015, having paced the competition with its M&A banking fees, and the investment bank is off to a riveting start in 2016.

Goldman Sachs and private equity firm Astorg Asset Management have been cleared by the European Commission to jointly acquire French drug maker HRA Pharma. HRA Pharma makes and markets pharmaceutical products for women health and endocrinology.

Not satisfied with just one purchase, Goldman Sachs is still on the market, partnering up with Park Square Capital to acquire HR company Northgate NGA from US private equity firm KKR.